MedPath

Study of properties of ropivacaine and dexmedetomidine with ropivacaine for upper limb surgeries

Phase 4
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2022/10/046660
Lead Sponsor
Jnu hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients who giving informed consent

Exclusion Criteria

Patients with previous history or clinical presentation with central or peripheral neurological

disease

2. Patients with previous history or clinical presentation with central or peripheral coagulopathy.

3. Patients with infection at the site of injection.

4. Patients allergic to any of the study drugs.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath